The Code Blue Series | A Growing Threat: Non-Communicable Diseases on Maternal Health
The Wilson Center’s Maternal Health Initiative, in partnership with EMD Serono, a business of Merck KGaA, Darmstadt, Germany, held its first public event of the CODE BLUE series. Experts spoke on the effects of NCDs on women of reproductive age and maternal mortality, smart innovations and programs designed to reduce the burden of NCDs, as well as gaps in research, policy, and funding.
CODE BLUE: The Importance of Integrating Care for Maternal Health and Non-Communicable Disease
“Non-communicable diseases have been the leading cause of death for women for at least the past 30 years but are often underreported and undertreated,” said Priya Kanayson, Policy and Advocacy Manager at NCD Alliance at a recent Wilson Center event on the impact of non-communicable diseases (NCDs) on maternal health. The event marked the official launch of the Maternal Health Initiative’s CODE BLUE series, developed in partnership with EMD Serono, a business of Merck KGaA, Darmstadt, Germany. Globally, in 2018, 73 percent of deaths among women were due to NCDs, amounting to 18 million women of reproductive age dying per year due to NCDs. The compounding effects of NCDs complicate women’s experiences in many unseen ways, and the rise and gravity of NCDs pose a growing and often overlooked challenge to maternal health worldwide.
Maternal mortality has declined since 2000, but there is still a long way to go, said moderator Dr. Ana Langer, Director of the Women and Health Initiative and Professor of the Practice of Public Health at Harvard’s T.H. Chan School of Public Health. While the global number of maternal deaths has declined by 35 percent, the vast majority of deaths occur in sub-Saharan Africa and South Asia. The United States is the only high-income country experiencing an increase in maternal mortality, although many of the deaths could be averted. About every 12 hours, a woman dies due to complications resulting from pregnancy, and more than 60 percent of those are preventable, said Dr. Lisa Waddell, Senior Vice President of Maternal Child Health and NICU Innovation and Impact Deputy Medical Director at March of Dimes. While it is important to discuss how the causes of maternal mortality and morbidity are distributed, it is extremely difficult to collect and measure data on different causes. A major issue to address, Dr. Langer said, is the role of indirect causes, including NCDs, on maternal mortality and morbidity.
Multiple Medical Conditions
It is important to look at “pregnancy as a window” on future health, said Charlotte Warren, Director of the Ending Eclampsia Project and Maternal and Newborn Health Portfolio Lead at Population Council. A common thread identified across the main NCDs discussed—cardiovascular disease, diabetes, hypertension, chronic respiratory disease, multiple sclerosis, thyroid disease, mental health, and cancer—was the prevalence of comorbidities and multiple morbidities. Cardiovascular disease, a leading cause of maternal death in the United States, is associated with a cycle of gestational and Type II diabetes, another common NCD in pregnancy, and obesity, a common risk factor across all NCDs, said Dr. Wanda Nicholson, Director of the Diabetes and Obesity Core and Professor of Obstetrics and Gynecology at UNC-Chapel Hill and Immediate Past Fellow-at-Large with the American College of Obstetricians and Gynecologists (ACOG).
Obesity before pregnancy can lead to hypertension, obesity, and glucose intolerance during and after pregnancy. This increases the risk of cardiovascular disease and diabetes during and after pregnancy, across a woman’s lifespan. Hypertensive disorders in pregnancy, another leading cause of maternal and newborn death, is associated with long-term risk of cardiovascular disease, said Warren. Hypertension leads to over 70,000 maternal deaths and 500,000 newborn deaths globally each year. Pre-eclampsia, a common hypertensive disorder, is associated with a 3.7-fold increase in future cardiovascular disease and stroke.
Mental health disorders are common co-morbidities of other NCDs. Between 18 to 25 percent of women living in low- and middle-income countries experience depression, said Kanayson. One in three cancer patients in the United States experience mental or emotional stress, according to the National Cancer Institute, and 40 percent specifically experience anxiety disorders. Studies show women are more likely to develop anxiety and depression in the first year after childbirth than any other time of life.
“We know that a third of maternal deaths occur in the postpartum period,” Dr. Nicholson said. This postpartum period of six to twelve weeks is relatively short compared to the nine months of pregnancy. Successful and comprehensive programs and interventions to prevent maternal mortality and morbidity during and after pregnancy are needed. While programs to address NCDs within maternal health are becoming more common in the United States, few programs take this integrated approach globally.
One that does is Population Council’s Ending Eclampsia project, a program funded by the U.S. Agency for International Development (USAID) to expand access to proven, underutilized interventions, tools, and resources to prevent detect early, and treat pre-eclampsia and eclampsia. In addition to addressing hypertensive disorders for pregnant women, said Warren, Ending Eclampsia works with women’s groups in-country to improve health literacy around successful treatment and prevention for hypertensive disorders in pregnancy. In the United States, March of Dimes has seen success in programs like Supportive Pregnancy Care, a model for group prenatal care that has increased support for mothers through group prenatal care to reduce preterm birth.
NCD Alliance has worked to integrate NCDs and reproductive and maternal health, notably with the Healthy Caribbean Coalition, an organization dedicated to NCD prevention and control through civil society involvement. NCD Alliance implemented cervical cancer screenings in six countries and trained educators to talk about family planning as well as NCD risk factor education, says Kanayson.
Spotting Heart Disease
The American College of Obstetricians and Gynecologists has recently implemented several programs to address cardiovascular disease within maternal health, said Dr. Nicholson. The Alliance for Innovation on Maternal Health Program (AIM) is funded by the Department of Health and Human Services to prevent maternal mortality and morbidity by working within hospital facilities, professional groups, and national public health programs. The AIM program has also developed collaborations among perinatal care providers and promoted maternity safety bundles, a set of best practices specific to individual NCDs and other causes of maternal mortality and morbidity. These maternity safety bundles revolve around the “four R’s”: readiness, recognition, response, and reporting. Additionally, ACOG has recently partnered with the American Heart Association to release a call to action to develop best practices to recognize cardiovascular disease early and throughout each stage of pregnancy.
Breaking Down Care Silos
A pilot program Dr. Nicholson launched at UNC-Chapel Hill called “Healthy Transitions” seeks to create a new and innovative model of care to increase surveillance of new mothers and integrate interventions for dietary changes, physical activity, and postpartum depression with women’s primary care. Promoting interventions such as these from a broader lens is one step towards breaking down the silos between NCDs and maternal health in primary care settings.
It is also important that programs address misconceptions around less common NCDs, such as multiple sclerosis (MS). Research shows that while there is a decrease in MS relapses during pregnancy, the postpartum period is associated with an increase in the frequency and severity of relapses in women living with MS. EMD Serono’s upcoming Family Planning Resource Center seeks to address the misconceptions around MS and fertility and serve as a resource for women with MS who want to start a family, said Terrie Livingston, Head of Patient Outcomes & Solutions for Neurology and Immunology and Medical Affairs and Multiple Sclerosis Patient Advocate at EMD Serono. Shortly after the birth of her second son, Livingston herself began experiencing symptoms of MS that went undiagnosed for two years, such as fatigue, cognitive issues like loss of short-term memory, hearing loss, vertigo, and trouble breastfeeding. Often, providers do not see these symptoms as a sign of MS, as they are also common features in the postpartum period for women.
Because of multiple misconceptions, women living with MS face stigma and often are told they should not start a family. Despite this, women with MS are having children and in fact, pregnancy rates among women with MS are higher today than those for women without MS. “I think there is a big opportunity to provide education” to women living with MS and their providers around planning for a family, said Livingston.
- Children born to mothers with NCDs are at a higher risk for negative health outcomes.
- Investing in women and children across all sectors can improve maternal health.
- More than 700 women die in the United States every year due to pregnancy-related causes.
CODE BLUE: Addressing NCDs in Maternal Health Starts with Increasing Access and Reducing Disparity
We’ve got a crisis impacting our mothers and a crisis impacting our babies, said Dr. Lisa Waddell, Senior Vice President of Maternal Child Health and NICU Innovation and Impact Deputy Medical Director at the March of Dimes, at a recent Wilson Center event launching the Maternal Health Initiative’s CODE BLUE series, developed in partnership with EMD Serono, a business of Merck KGaA, Darmstadt, Germany. She was referring to non-communicable diseases (NCDs), which impact maternal health in the United States and globally. NCDs kill 18 million women of reproductive age each year, accounting for two in every three deaths among women.
Lack of Access: Maternity Care Deserts
In the United States, a lack of care poses a problem. Some 5 million women currently live in “maternity care deserts,” counties where no hospital offers obstetric services and where no maternal health providers work. “When you’re talking about the rise of diabetes and the rise of chronic health conditions—and then women are not able to get that care before pregnancy, can’t get that care during pregnancy—it should be no surprise that we’ve got these challenges,” said Dr. Waddell.
Barriers to accessing healthcare increase the risk of undiagnosed cardiovascular disease and other NCDs in pregnant women, said Dr. Wanda Nicholson, Director of the Diabetes and Obesity Core and Professor of Obstetrics and Gynecology at UNC-Chapel Hill and Immediate Past Fellow-at-Large with the American College of Obstetricians and Gynecologists (ACOG).
Inequity in access is also a global problem. For example, in target countries for the Ending Eclampsia project, women who lack of access to blood pressure monitors face increased risk of pre-eclampsia and postpartum hemorrhage, said Charlotte Warren, Director of the Ending Eclampsia Project and Maternal and Newborn Health Portfolio Lead at Population Council. Women in the project often had trouble getting the right information on how to prevent and treat NCDs. “They’re really not getting the care they should,” said Warren.
Disparities in Maternal Health
Lack of access to maternity care is often exacerbated by racial disparities in maternal health. In the United States, African American women are 3.3 times more likely to die from pregnancy and childbirth-related causes than white women. The prevalence of NCDs in the United States reflects these disparities. For example, African American women are three times more likely to die from cardiovascular disease than white women. And the maternal mortality rate for American Indian/Alaska Native women is 2.3 times higher than white women’s.
Maternal mortality is just the tip of the iceberg, said Dr. Waddell. Under the iceberg, underlying determinants like racism, systemic barriers in the health system, differences in economic stability, and different environmental exposures contribute to disparities in health outcomes. These determinants also contribute to gender disparities within the overall burden of NCDs. For example, in 2016, 1.5 million women died due to respiratory conditions, said Priya Kanayson, Policy and Advocacy Manager at NCD Alliance. Globally, women and girls are exposed to more indoor air pollution due to harmful cooking materials, which contributes to higher rates of respiratory disease. Poor treatment from a human relations standpoint can also lead to worse health. Disrespect and abuse during childbirth, for example, can contribute to negative birth outcomes and delay diagnosing symptoms of complications related to NCDs, said Warren.
Sometimes simply getting a correct diagnosis can be an uphill battle. For two years, Terrie Livingston, Head of Patient Outcomes & Solutions for Neurology and Immunology and Medical Affairs and Multiple Sclerosis Patient Advocate at EMD Serono, suffered from mysterious symptoms. After the birth of her second son, the symptoms intensified. “I had this profound fatigue that I didn’t have with my first child, where I couldn’t even move off the couch,” she said. “And it took every effort for me to be able to breastfeed my child.”
After experiencing short-term memory lapses, hearing problems, and vertigo, she went to see her doctor. Doctors first misdiagnosed her and treated her accordingly, but her symptoms persisted and worsened. Her whole right side became weak and it became hard to walk. Her doctors did not think that she had Multiple Sclerosis (MS), because she is not the typical MS patient, said Livingston, who is Asian American. MS was once thought to primarily affect white women, but African American women now have the highest rate of MS in the United States. In addition, the symptoms of MS are often common in otherwise healthy postpartum women, so providers often do not see them as a sign of something more, like MS.
Priorities Should Address Underlying Determinants
To tackle the maternal health crisis and address the impact of NCDs on maternal health, it is important to make maternity care more accessible to all people, said Dr. Waddell. Advocates in the United States have pushed to expand Medicaid insurance coverage for women from 60 days to one full year following pregnancy. Women who have a higher risk of developing cardiovascular conditions or other NCDs following pregnancy should be under continued surveillance and treatment past the first postpartum visit through one full year after childbirth, said Dr. Nicholson. And collaboration in maternal health should go beyond the “OB/GYN world” and include midwives and nurse practitioners, she said, especially in rural areas and “maternity care deserts.”
In order to address social norms and racial disparities in health outcomes, we need to start with the social determinants of health, said Dr. Nicholson. Health systems should also prioritize implicit bias and cultural competency training for providers to reduce the barriers that minority women face in the healthcare system and improve health outcomes. Globally, more work needs to be done to improve women’s experiences in healthcare settings, said Warren.
Taking a Life-Course Perspective
Non-communicable diseases can have an “intergenerational effect,” said Kanayson. Children of women with NCDs face a higher risk of developing NCDs throughout their own lifespans. In order to fully address the impact of NCDs on maternal health, we need to make an effort to look further upstream to focus on interventions to reduce NCD risk factors even prior to conception, said Dr. Nicholson. A prevention-based model rather than a treatment-based model would address NCDs before they cause complications in pregnancy or later in life, the panelists said.
Women should be the center of care, said Warren. “They should be treated as individuals. And it doesn’t matter who they are, what they are, or where they come from, but we really need to focus on the woman and her lifestyle, and how to help her have a healthy life.”
Written by Deekshita Ramanarayanan, edited by Sandra Yin
Documents & Downloads
- Priya Kanayson's Presentation: The Global Landscape for NCDs and Maternal Health Download
- Dr. Ana Langer's Presentation: Code Blue Series: The Growing Threat of Non-Communicable Diseases on Maternal Health Download
- Terrie Livingston's Presentation: Maternal Health Multiple Sclerosis Download
- Dr. Wanda Nicholson: CODE BLUE SERIES Addressing the growing threat of non-communicable diseases on maternal healthDownload
- Dr. Lisa Waddell's Presentation: Healthy Moms. Strong Babies. Download
- Charlotte Warren's Presentation: Pregnancy as a Window for Future Health Download
Dr. Wanda Nicholson
Dr. Lisa Waddell
Maternal Health Initiative
Life and health are the most basic human rights, yet disparities between and within countries continue to grow. No single solution or institution can address the variety of health concerns the world faces. By leveraging, building on, and coordinating the Wilson Center’s strong regional and cross-cutting programming, the Maternal Health Initiative (MHI) promotes dialogue and understanding among practitioners, scholars, community leaders, and policymakers. Read more
Global Risk and Resilience Program
The Global Risk and Resilience Program (GRRP) seeks to support the development of inclusive, resilient networks in local communities facing global change. By providing a platform for sharing lessons, mapping knowledge, and linking people and ideas, GRRP and its affiliated programs empower policymakers, practitioners, and community members to participate in the global dialogue on sustainability and resilience. Empowered communities are better able to develop flexible, diverse, and equitable networks of resilience that can improve their health, preserve their natural resources, and build peace between people in a changing world. Read more
Thank you for your interest in this event. Please send any feedback or questions to our Events staff.